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[57] ABSTRACT
A solid phase immunoassay comprises the steps of
(a) immobilizing an immunoreagent on the surface of a
carrier comprised of an inert synthetic resin selected
from the group consisting of polyimides and polyflu-
orinated synthetic resins,
(b) contacting the immunoreagent with a complemen-
tary immunoreagent whereby an immunocomplex
immobilized on said carrier is formed,
(c) quantitating the immobilized immunocomplex.
An element useful in conducting this solid phase immu-
noassay is prepared by a process of treating the surface
of an article comprised of a synthetic polymer selected
from the group consisting of polyimides and polyfluori-
nated synthetic resins to make it adsorptive of an im-
munoreagent which comprises the steps of
(a) thoroughly rinsing the surface with a water-miscible
organic solvent,
(b) thoroughly rinsing the surface with water.
42 Claims, 2 Drawing Sheets
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SOLID PHASE IMMUNOASSAY USING
IMMUNOREAGENTS IMMOBILIZED ON INERT
SYNTHETIC RESIN SURFACES
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to solid phase immunoassays
using immobilized immunoreagents and more particu-
larly to elements for solid phase immunoassay compris-
ing immunoreagents immobilized on carriers made of
inert synthetic resins. The invention also relates to
methods of preparing synthetic resin surfaces for use as
carriers for immunoreagents.
2. Description of the Prior Art
Immunoassay using immobilized immunoreagents is
an analytical method widely used in biochemical analy-
sis. In the conventional procedure an immunoreagent,
e.g., an antigen or antibody, is first immobilized on the
surface of an analytical element, e.g., a test tube, a rod or
stick, beads of glass or plastic, or the like. The immo-
bilized immunoreagent is then contacted with an analy e
solution containing a complementary immunoreagent,
whereby an immobilized immunocomplex is formed.
The immobilized immunocomplex can then be easily
separated from the unreacted analyte solution, e.g., by
simply removing the analyte solution by aspiration,
decantation, or the like, preferably with repeated
washing of the immobilized immunocomplex. The sepa-
rated immobilized immunocomplex may then be sub-
jected to further processing to quantitate the amount of
immunocomplex. For example, in a radioimmunoassay,
the amount of adsorbed complex may be determined by
counting radioactive disintegrations; in an enzyme-
linked immunosorbent assay (ELISA) the adsorbed
complex which has an enzyme coupled thereto, is con-
tacted with a substrate for the enzyme to produce a
detectable product; in an immunofluorescent assay, the
fluorescent intensity of a fluorescent substance linked to
the immunocomplex may be measured, or the like.
Among the many different materials which have been
used as carriers for an immunoreagent are glass, metal,
and various plastics such as polystyrene, polyvinyl
chloride, silicone resins, polyethylene and the like. In
some cases the immunoreagent has been immobilized by
covalent bonding to the carrier, while in other cases
adsorption of the immunoreagent has proved adequate.
Synthetic resin carriers have been widely used because
of their economy and convenience and ease of handling,
but problems remain in immobilizing enough im-
munoreagent on their surfaces for maximum sensitivity
of the immunoassay, especially when the reagent is
merely adsorbed onto the surface. Furthermore, the
synthetic resin carriers used previously are inadequate
for some of the newer immunoassay techniques such as
thermochemiluminescent immunoassay, which requires
that the carrier with immobilized immunocomplex be
heated to relatively high temperatures, i.e., 200° C. to
300° C. The conventional plastic carriers cannot be used
under these conditions because they soften or even melt
at such temperatures.
On the other hand, certain plastics are known which
can be used at temperatures of 200° to 300° C. without
melting or deformation, for example, polyimide syn-
thetic resins, and polytetrafluoroethylene (PTFE) and
related fluorinated olefin polymers. However, these
resins are very inert and non-adhesive, and it has been
thought that satisfactory adsorption of immunoreagents
to such surfaces was not possible.
Prior workers in this field do not appear to have
attempted to use a polyimide as a carrier for an im-
munoreagent in a solid phase immunoassay.
Some attempts have been made to use PTFE as a
carrier for solid phase immunoassay, but the procedures
have been unsuccessful or have had serious drawbacks.
Shekarchi, et al., J. Clin. Microbiology 16(6), 1012-
1018 (December, 1982) disclose an immunoassay
procedure wherein an immunoreagent is immobilized on
a small stick, i.e., "microstick", for easy manipulation of
the reagent and the immunocomplex. While a number of
materials were investigated for use in such microsticks,
including stainless steel, nylon, polycarbonate,
polystyrene and PTFE, it was found that the PTFE,
cleaned by the conventional procedure of rinsing with
6N HCl, adsorbed very little of the immunoreagent as
compared with the other materials and could not be used
as a base for the immunoreagent until it had been coated
with polycarbonate or nitrocellulose.
German Offenlegungsschrift No.32 00 822, published
July 21, 1983, discloses a method for activating the
surface of PTFE articles, in order to bond immunorea-
gents covalently, by contacting the PTFE surface with
an ammoniacal solution of sodium, followed by treat-
ment with carbodiimide. The process was apparently
attempted because it was found that adsorption of the
immunoreagent on PTFE was unsatisfactory. This pro-
cess is complex and uses reagents which are difficult to
handle and even dangerous. Furthermore, there is some
question whether the procedure of this German applica-
tion actually can immobilize a useful amount of im-
munoreagent on PTFE.
Hence, a need has continued to exist for improved
immunoassay procedures using immunoreagents immo-
bilized on inert carriers such as polyimides and fluori-
nated polymers and for a practical method of immobi-
lizing immunoreagents on the surfaces of such synthetic
resins.
SUMMARY OF THE INVENTION
It has now been found that a solid phase immunoassay
element comprising an immunoreagent adsorbed onto
th  surface of a heat resistant synthetic resin such as a
polyimide or PTFE can be prepared by adsorbing the
immunoreagent onto the surface by simply incubating
the surface in an aqueous solution of the immunorea-
g nt, provided that the surface of the synthetic resin has
first been cleaned by thorough rinsing with a water-mis-
cible organic solvent followed by thorough rinsing with
wa er.
The invention further comprises a solid phase immu-
noassay procedure using an immunoreagent immobi-
lized on a carrier made of a polyimide or a polyfluori-
nated synthetic resin.
The invention further comprises a process for treating
the surface of an article comprised of a synthetic
polymer selected from the group consisting of polyi-
mides and polyfluorinated synthetic resin polymers to
make it receptive to adsorption of an immunoreagent
this process comprising the steps of
(a) t oroughly rinsing the surface with a water-misci-
ble organic solvent, and
(b) thoroughly rinsing the surface with water.
An immunoreagent may then be adsorbed onto the
surface of the cleaned synthetic resin by contacting the
















Thus, it is an object of the invention to provide a
method of solid phase immunoassay using an im-
munoreagent immobilized on the surface of an inert
synthetic resin.
A further object is to provide an immobilized im-
munoreagent.
A further object is to provide an immunoreagent
immobilized on a synthetic resin surface, where the
synthetic resin is a polyimide or a polyfluorinated syn-
thetic resin.
A further object is to provide a method for treating an
inert synthetic resin surface to make it adsorptive to
immunoreagents.
A further object is to provide a method of preparing an
immobilized immunological reagent.
A further object is to provide a method of immobiliz-
ing an immunological reagent on a polyimide synthetic
resin surface.
A further object is to provide a method of immobiliz-
ing an immunological reagent on a polyfluorinated pol-
ymer surface.
Further objects of the invention will become apparent
from the description of the invention which follows.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 illustrates the results of the solid phase
enzyme-linked immunosorbent assay of Example 3
using a conventional polystyrene carrier.
FIG. 2 illustrates the results of the solid phase en-
zyme-linked immunosorbent assay of Example 3 using a
polyimide resin carrier.
FIG. 3 illustrates the results of the solid phase en-
zyme-linked immunosorbent assay of Example 3 using a
PTFE carrier.
DETAILED DESCRIPTION OF THE
INVENTION AND PREFERRED
EMBODIMENTS
The solid phase immunoassay of the invention using
an immunoreagent immobilized on an inert resin surface
of a polyimide or a polyfluorinated synthetic resin is
capable of giving greater sensitivity than assays using
immunoreagents immobilized on conventional carriers
such as polystyrene and the like.
Solid phase immunoassay elements comprising an
immunoreagent immobilized on a carrier surface of a
polyimide or polyfluorinated synthetic resin are essen-
tial to the practice of the immunoassay of the invention.
Such elements are useful in the practice of conventional
immunoassays, but are especially useful for thermo-
chemiluminescence immunoassays which require that
the carrier with an immobilized immunocomplex be
heated to relatively high temperatures, e.g., 200° C. to
300° C.
The solid phase immunoassay elements of this inven-
tion use carriers comprised of a polyimide or a polyflu-
orinated synthetic resin. The polyimide resins are inert
heat-resistant synthetic resins which are characterized
by the presence of the phthalimide structure in the
backbone. A preferred polyimide is a condensation
polymer of pyromellitic acid and bis(4-aminophenyl)ox-
ide, sold by E. I. du Pont de Nemours & Co. under the
name Kapton ®. The process may also employ polyflu-
orinated synthetic resins having surfaces of low surface
energy which have hitherto been thought to be too non-
adhesive for adsorption of immunoreagents. Such
polymers include polymers of perfluorinated carbon-
ates, polymers of perfluorinated epoxy compounds and
especially addition polymers of ethylenically unsatu-
rated hydrocarbons such as polytetrafluoroethylene,
poly(chlorotrifluoroethylene) and the like. These mate-
rials are manufactured by a number of suppliers, e.g., by
the Du Pont Co., under the name Teflon ®.
The water-miscible organic solvent used in the prepa-
ration of the immunoassay elements of the invention
may be any solvent which can produce the requisite
clea liness of the surface of the synthetic resin, and is
sufficiently miscible with water to be completely re-
moved by subsequent thorough rinsing with water. Such
solvents include lower aliphatic alcohols, e.g., C1-C4
aliphatic alcohols such as methanol, ethanol, n-
prop ol, isopropyl alcohol, n-butanol, isobutanol, sec.-
butyl alcohol and tert.-butyl alcohol; lower aliphatic
ketones, e.g., acetone, methyl ethyl ketone, and the like,
dioxan, dimethylformamide, dimethyl sulfoxide,
acetonitrile, lower (C1-C4) glycols such as ethylene
glycol and propylene glycol, and lower aliphatic ethers
having a total of about 3 to 6 carbon atoms, e.g., 2-
methoxyethanol, 2-ethoxyethanol and the like. Mixtures
of solvents may also be used. Preferred solvents are
lower aliphatic alcohols, and a most preferred solvent is
ethanol.
The solvent rinsing step is preferably conducted by
contacting the surface of the synthetic resin with clean
solvent for a period of time required to thoroughly clean
the surface. The extract experimental conditions may
vary with the solvent chosen, but the evaluation of the
results in order to choose the proper condition may be
simply carried out by using the surface in a standard
immunoassay. A surface which has been inadequately
cleaned will poorly adsorb the immunoreagent and
manifest this poor adsorption by a low sensitivity in the
immunoassay. It is preferable to have the solvent which
contacts the synthetic resin surface as free as possible of
contaminants. This can be accomplished by continu-
ously supplying fresh solvent to the surface, e.g., in a
flowing system, or by frequent changes of solvent when
the cl aning is conducted by a batch process. The sol-
vent will ordinarily be used in an anhydrous state for
maximum solvent power for organic contaminants on
the esin surface. However, the invention is also in-
tended to include the use of solvents containing small
amounts of water which do not seriously interfere with
the solvent properties of the solvents toward organic
surface contaminants.
It is preferred to conduct the solvent rinsing step by
contacting the surface with the solvent at its boiling
t perature. Accordingly water-miscible solvents hav-
ing boiling points between about 40° C. and about 200°
C. are preferred. The solvent rinsing step is therefore
conveniently carried out by placing the articles to be
coated, e.g., disks of the polymer to be used in im-
munosorbent assays, in a flask containing the solvent
and heating to reflux temperature. The time of the sol-
ve t insing step will also vary depending on the solven
and its temperature. A relatively short contact time, e.g.,
o e- alf hour, may produce a surface which will adsorb
some immunoreagent. However, it is preferable to keep
the surface in contact with the solvent for a relatively
long period of time, e.g., one or two days, in order to
assure maximum cleaning and maximum adsorption of
immunoreagent, which assures the highest sensitivity of
the immunoassay. It is also preferable to change the
solvent several times in the course of the rinsing step to
insure maximum cleanliness of the solvent in the final
















A preferred procedure is to contact the surface of the
synthetic resin carrier with ethanol at refluxing temper-
ature for a period of one to two days with frequency
changes of solvent.
After the completion of the solvent cleaning step, the
solvent-rinsed surface is then thoroughly rinsed with
pure water, e.g., distilled or deionized water, to remove
all traces of the solvent. Again, the preferable procedur
is to immerse the articles in boiling water in a refluxing
apparatus, for several hours, with several changes of
water. The presence of residual solvent on the surface
of the synthetic resin interferes with the adsorption of
the immunoreagent and hence insufficient water rinsing
is readily detected by the practitioner by simple use of a
standard immunoassay. Evidently, the necessary length
of the water rinsing step and the number of changes of
fresh water can be easily determined by the practioner
using this criterion.
If desired the carriers may be dried after the water
rinsing step. The drying is preferably conducted by
draining the water from the carriers and allowing the
residual water to evaporate. It is preferable to assure
complete dryness, especially when the carriers are to be
used for a thermochemiluminescent assay, by drying in
an oven at an elevated temperature, e.g., 200° C. to
300° C., for an extended period of time. Preferred
drying conditions are 300° C. overnight.
The articles prepared by the cleaning process, either
immediately after the rinsing step, without drying the
surface, or after the surface has been dried, may then be
coated with an immunoreagent by a relatively conven-
tional adsorption step wherein the articles are contacted
with an aqueous solution of the immunoreagent in a
suitable buffer for a period of time to allow physical
adsorption to occur to a sufficient extent. The basic
process for this adsorption step is closed by Catt, U.S.
Pat. No. 3,646,346. For example, the article may be
contacted with an aqueous solution of an antibody at a
concentration of 0.1 mg/ml in 0.1M tris(hydroxyme-
thyl)aminomethane (Tris) at a pH of about 7.6 at 4° C.
for an extended period of time, e.g. 2 or more days. The
coated articles are then thoroughly washed with dis-
tilled water and are ready for use in immunoassay pro-
cedures.
Any immunoreagent conventionally used in immuno-
assay can be adsorbed to the surface of the inert syn-
thetic resin carrier used in this invention. Ordinarily, the
immunoreagent will be an antibody or an antigen and
generally the immunoreagent will be a proteinaceous
material.
While the preferred conditions are given above, ef-
fective ranges are rather broad, and it will be under-
stood by those skilled in the art that the conditions may
be varied, provided that the essential steps are per-
formed. The success of the treatment under a given set
of conditions is easily evaluated by simply measuring
the amount of immunoreagent absorbed, e.g., by use in
a conventional standard immunoassay.
The invention will be illustrated by the following
examples which are not intended to be limiting. In the
examples all parts and percentages are by weight.
EXAMPLE 1
This example illustrates the surface treatment process
of process of this invention and immobilization of im-
munoreagent.
About 150 disks of a polyimide synthetic resin (Kap-
ton 500H ®, manufactured by the du Pont company)
having a diameter of 9 mm and a thickness of 125 mi-
crometers were placed in a flask equipped with a reflux
co denser, covered with ethanol, and rinsed with ethanol
at reflux temperature for a period of one day with several
changes of the ethanol solvent. The disks were then
rinsed with distilled water at reflux temperature for
several hours with several changes of distilled water.
The disks were then removed from the flask and dried in
an oven at a temperature of 300° C. overnight.
The dried disks were then placed in 40 ml of a solu-
tion of 0.1 mg/ml of antibody in 0.1M Tris buffer(pH
7.6) and 0.02% NaN3, at a temperature of 4° C. The
disks were gently shaken during the coating procedure
which was continued for a period of 2 days. The coated
disks were then washed in distilled water and could be
preincubated, if desired, to prepare them for use in
immunoassay by incubating them in an aqueous solution
of 4% bovine serum albumin (BSA) in a 10 mM Tris
buff  (pH 8.0), 0.15M NaCl, 0.05% polyoxyethylene
sor itan surfactant (Tween 20 ®) (Buffer A) for at least
one hour.
EXAMPLE 2
The procedure of Example 1 was used to prepare and
coat about 150 disks of polytetrafluoroethylene having a
diameter of 9 mm and a thickness of 500 micrometers.
EXAMPLE 3
This example illustrates a comparison of ELISA con-
ducted with the immunological reagent adsorbed by
conventional procedures on a polystyrene microtiter
pl te and on carriers coated according to this invention.
Disks of polyimide or of polytetrafluorethylene were
coated by the procedure of Example 1 with goat antihu-
m n Immunoglobulin G (IgG) (7S) (Nordic), human IgG
(Sigma) and BSA (Sigma). Polystyrene microtiter plates
(Costar, Holland) were coated for one week with the
same antibodies and with BSA by contacting them for a
period of one week with a solution of 0.1 mg protein per
ml, 0 1M carbonate buffer, pH 9.6, at a temperature of
4° C. Each well of the plates contained 0.1 ml of the
solution. After the different carrier polymers were coated
with the different immunoreagents, the solid phase
immunoassay procedures were identical.
The coated carriers were preincubated for one hour
with 0.2 ml of Buffer A. After washing with distilled
water, the disks were incubated with 0.2 ml human IgG
standards (0; 1; 2.5; 5; 7.5; 10; 20; 40; 60; 100; 500;
1000 ng human IgG per ml of Buffer A) for one hour at
37° C. while shaking in a waterbath. Subsequently, the
disks were again washed with distilled water by
decantation and incubated with 0.2 ml of an aqueous
solution containing 1 microgram of peroxidase labeled
goat-antihuman conjugate (Nordic) per milliliter of
Buffer A at 37° C. in a waterbath with shaking. After
removal of unbound conjugate, peroxidase activity on
the d sks was measured by means of the conversion of
orthophenylenediamine to a colored product. Carriers
coated with immunoreagent were incubated in the dark
with 0.2 ml of M-phosphate buffer, pH 5.0, 0.0045%
H2O2, 2.10
-3M ortho-phenylenediamine HCl (UCB) for
one hour. Color development was stopped by adding of
0.5 ml of 1N H2SO4. The optical density of the color was
measured at 495 nm with a Zeiss spectrophotometer.
FIG. 1 shows the results of an immunoassay on a
polystyrene carrier. FIG. 2 shows the results of the same
immunoassay using the polyimide (Kapton 500H ®)
















FIG. 3 shows the results of the same immunoassay
performed using PTFE disks coated by the process of
this invention.
In the figures the symbols I indicate the values mea-
sured for the series of human IgG standards. Each data
bar represents a triplicate measurement. The vertical
length of the bar represents the range of the repeated
determinations. Note that at a concentration below 20
ng/ml the measurements are so reproducible that the
data bar has hardly any vertical length. The triangles
indicate the measured values for the negative control
(BSA) and the circles represent the measured values for
the positive control (disks coated with pure antigen,
human IgG).
FIGS. 2 and 3 show that the peroxidase activity of the
adsorbed immunocomplex is substantially greater for
the polyimide and PTFE carriers prepared according to
this invention than for the conventional polystyrene
carrier. Accordingly, is evident from the results of the
experiment that the inert synthetic resin surfaces
prepared and coated with immunoreagent by the process
of this invention yield results superior to the con-
ventional immunoassay using polystyrene microtiter
plates.
EXAMPLE 4
This example illustrates the results of comparative
immunoassays using polyimide carriers prepared by
cleaning processes different from that of this invention.
A. Acidic cleaning treatment.
Kapton disks were contacted with 98% sulfuric acid
for one minute at room temperature, washed with dis-
tilled water, and immediately (without drying) incu-
bated with either human serum albumin (antigen) or
human IgG (non-antigen). The incubated disks were
then contacted with an aqueous solution of peroxidase-
labeled rabbit-anti-human serum albumin (antibody). It
was found that the amount of antibody bound to the
carrier was the same for both the antigen-coated carrier
and the carrier coated with non-antigen protein. Ac-
cordingly the antibody binding of the polyimide carrier
prepared by an acid cleaning treatment is completely
non-specific, and such a carrier is useless for solid phase
immunoassay.
B. Basic cleaning treatment
Polyimide disks were treated with 5% KOH in dis-
tilled water for 5 minutes at room temperature, then
washed a few times with distilled water. Analytical
disks were then incubated with a series of human IgG
standards of various concentrations according to the
procedure of Example 3, while control disks were
coated by incubation with a solution of bovine serum
albumin (BSA). The immunoasay was conducted by the
procedure of Example 3. It was found that the blank
value of bound peroxidase activity (i.e., for the disks
coated with BSA) was very high, about 0.80 to about
1.0 optical absorbance units. While the measured values
of bound peroxidase activity for the disks coated with
human IgG were measurably greater than the blank
value, it is evident that such a high blank value produces
an assay having inferior sensitivity and accuracy.
EXAMPLE 5
This example illustrates the specific nature of the
pretreatment process of this invention
Glass disks about 1.0 cm in diameter were treated by
the process of Example 1 and used in an immunoassay
as described in Example 3. It was found that the blank
value (BSA coated disks) was rather high, about 0.25
optical absorbance units, while the measured value for
an analyte concentration of 100 ng/ml (human IgG) was
only bout 0.40, i.e., only about 0.15 optical absorbance
units greater than the blank value. The same process
applied to glass beads about 5-7 mm in diameter gave
v n poorer results; the beads appeared to have no
specific binding power after being subjected to the con-
ventional adsorption process to coat them with an im-
munoreagent. Such results indicate that this process is
n t suitable for use with glass carriers. Accordingly, it
is evident that the process of the invention is not a gen-
eral cleaning process, but rather a cleaning process
specially adapted to cleaning and preparing carriers of
the claimed synthetic resins.
The invention having now been fully described, it
should be understood that it may be embodied in other
specific forms or variations without departing from its
spirit or essential characteristics. Accordingly, the em-
bodiments described above are to be considered in all
respects as illustrative and not restrictive, the scope of
the invention being indicated by the appended claims
rather than by the foregoing description, and all
changes which come within the meaning and range of
equivalency of the claims are intended to be embraced
therein.
What is claimed is:
1. A solid phase immunoassay comprising the steps of
(a) immobilizing an immunoreagent on the surface of
a carrier comprised of an inert synthetic resin se-
lected from the group consisting of polyimides,
(b) contacting said immunoreagent with a comple-
mentary immunoreagent whereby an immunocom-
plex immobilized on said carrier is formed,
(c) quantitating said immobilized immunocomplex.
2. The immunoassay of claim 1 wherein said poly-
imide is a polymer of pyromellitic acid and bis(4-
aminophenyl)oxide.
3. The immunoassay of claim 1 wherein said im-
munoreagent is a protein.
4. The immunoassay of claim 1 wherein said im-
munoreagent is an antibody.
5. The immunoassay of claim 1 wherein said im-
munoreagent is an antigen.
6. An element for use in a solid phase immunoassay
comprising an immunoreagent immobilized on the sur-
face of a carrier comprised of an inert synthetic resin
selected from the group consisting of polyimides.
7. The element of claim 6 wherein said polyimide is a
polymer of pyromellitic acid and bis(4-aminophenyl)-
oxide.
8. The element of claim 6 wherein said immunorea-
gent is a protein.
9. The element of claim 6 wherein said immunorea-
gent is an antibody.
10. The element of claim 6 wherein said immunorea-
gent is an antigen.
11. The immunoassay of claim 1 wherein the surface
of the carrier is treated to make it receptive to adsorp-
tion of an immunoreagent prior to immobilizing an
immunoreagent thereon by the process comprising the
steps of
(a) thoroughly rinsing the surface with a water-misci-
ble organic solvent, and
(b) thoroughly rinsing the surface with water.
12. The immunoassay of claim 11 wherein said sol-
















13. The immunoassay of claim 12 wherein said alco-
hol is ethanol.
14. The immunoassay of claim 11 wherein said sol-
vent rinsing step is carried out at a temperature equal to
the boiling point of the solvent.
15. The immunoassay of claim 11 wherein said sol-
vent rinsing step is carried out for a period of from
about one-half hour to about four days.
16. The immunoassay of claim 15 wherein said sol-
vent rinsing step is carried out for at least one day.
17. The immunoassay of claim 11 wherein said water
rinsing step is carried out at a temperature equal to the
boiling point of water.
18. The immunoassay of claim 11 wherein the surface
of the carrier is dried after the water rinsing step.
19. The immunoassay of claim 18 wherein said drying
step is carried out at a temperature greater than 200° C.
20. The immunoassay of claim 19 wherein said drying
step is carried out at a temperature of about 30 ° C.
21. The immunoassay of claim 11 wherein the treated
surface is contacted with an aqueous solution containing
an immunoreagent.
22. A solid phase thermochemiluminescent immuno-
assay comprising the steps of
(a) thoroughly rinsing the surface of a carrier com-
prised of an inert synthetic resin selected from the
group consisting of polyfluorinated synthetic resins
with a water-miscible organic solvent,
(b) thoroughly rinsing the surface of the carrier with
water,
(c) contacting the surface of the carrier with an aque-
ous solution of a first immunoreagent for a sufficient
time to immobilize at least a portion of the first
immunoreagent on said surface,
(d) contacting said immobilized first immunoreagent
with a complementary immunoreagent whereby an
immunocomplex immobilized on said carrier is
formed,
(e) contacting the surface of the carrier having the
immobilized immunocomplex thereon with an im-
munoreagent that is immunoreactive with either the
complementary immunoreagent or the first
immunoreagent and has a thermochemiluminescent
label to form a detectable labelled immunocomplex
immobilized on said carrier,
(f) heating said carrier to a temperature at which the
thermochemiluminescent label becomes lumines-
cent, and
(g) detecting said immobilized thermochemilumines
cent immunocomplex.
23. The immunoassay of claim 22 wherein said poly-
fluorinated synthetic resin is a polymer of a polyfluori-
nated ethylenically unsaturated hydrocarbon.
24. The immunoassay of claim 23 wherein said poly-
fluorinated synthetic resin is polytetrafluoroethylene.
25. The immunoassay of claim 22 wherein said first
immunoreagent is a protein.
26. The immunoassay of claim 22 wherein said first
immunoreagent is an antibody.
27. The immunoassay of claim 22 wherein said first
immunoreagent is an antigen.
28. The immunoassay of claim 22 wherein said sol-
vent is a C1-C4 aliphatic alcohol.
29. The immunoassay of claim 28 wherein said alco-
hol is ethanol.
30. The immunoassay of claim 22 wherein solvent
rinsing is carried out at a temperature equal to the boil-
ing point of the solvent.
31. The immunoassay of claim 22 wherein solvent
rinsing is carried out for a period of from about one-half
hour to about four days.
32. The immunoassay of claim 31 wherein solvent
rinsing is carried out for at least one day.
33. The immunoassay of claim 22 wherein water
rinsing is carried out at a temperature equal to the boil-
ing point of water.
34. The immunoassay of claim 22 wherein the surface
of the carrier is dried after water rinsing.
35. The immunoassay of claim 34 wherein said drying
step is carried at a temperature greater than 200° C.
36. The immunoassay of claim 35 wherein said drying
step is carried out at a temperature of about 300° C.
37. An element for use in the solid phase thermo-
chemiluminescent immunoassay of claim 22, co prising
an immunoreagent immobilized on the surface of a car-
rier comprised of an inert synthetic resin selected from
the group consisting of polyfluorinated synthetic resins,
wherein the surface of the carrier has been prepared by
thorough washing with a water-miscible organic solvent
followed by thorough washing with water before
immobilizing the immunoreagent thereon.
38. The element of claim 37 wherein said polyfluori-
nated synthetic resin is a polymer of a polyfluorinated
ethylenically unsaturated hydrocarbon.
39. The element of claim 38 wherein said polyfluori-
nated synthetic resin is polytetrafluoroethylene.
40. The element of claim 37 wherein said immunorea-
gent is a protein.
41. The element of claim 37 wherein said immunorea-
gent is an antibody.
42. The element of claim 37 wherein said immunorea-
gent is an antigen.
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